BSE filing, NSE: WINDLAS. Summary written from the filing by ALFA Finder's alert engine.
Windlas Biotech Ltd: key numbers
- Share price
- ₹881.10
- Market cap
- ₹1,849 Cr
- Revenue (annual)
- ₹904.1 Cr
- Net profit (annual)
- ₹66.44 Cr
- P/E (TTM)
- 27.8×Sector 48.7×
- Promoter holding
- 63.31%+0.00% QoQ
- FII holding
- 2.09%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Windlas Biotech Ltd
All →Windlas Biotech Board Meeting Date
Windlas Biotech intimated that its Board meeting is scheduled for 5 November 2026 to consider unaudited standalone results for Q1 FY27. No monetary figure is disclosed in this advance notice.
Windlas Biotech Other Announcement
This quarterly shareholding pattern statement for Windlas Biotech Ltd, covering the period ended September 30, 2026, provides the company's equity ownership breakdown.
Windlas Biotech Management Change
Windlas Biotech appointed Aashish Mehra and Soni Saran Singh as Independent Directors. Vivek Dhariwal resigned as Independent Director and Chairman of the Board.
Windlas Biotech Earnings Call Transcript: Key Takeaways
Windlas Biotech reported record quarterly revenue driven by 29% growth in CDMO vertical. Management focuses on operational excellence and capacity expansion via Plant 6 commercialization.
Windlas Biotech Results Update
Windlas Biotech reported Q1 FY27 revenue of Rs 248 crore, an 18% YoY growth. The release highlights an adjusted EBITDA of Rs 34 crore and PAT of Rs 25 crore.
Windlas Biotech Investor Presentation: Key Takeaways
Windlas Biotech reported Q1FY27 revenue of ₹248 Cr (18% YoY). Adjusted EBITDA and PAT grew 26% and 37% respectively, excluding ESOP costs, driven by CDMO expansion.
Other board meeting date announcements
All →HIM Teknoforge Board Meeting Date
Him Teknoforge Ltd scheduled a board meeting for 05 Nov 2026 to approve un-audited Q1 and H1 FY27 results. No financial figures or decisions are reported in this advance notice.
IL&FS Investment Managers Board Meeting Date
IL&FS Investment Managers Ltd intimated a board meeting on 4 Nov 2026 to consider Q2/H1 FY27 financial results. No results or decisions are reported in this filing.
Emrock Corporation Board Meeting Date
Emrock Corp scheduled a board meeting on 04 Nov 2026 to approve Q2 results and a new MOA object. No financial figures or decisions are yet in place.
Sattrix Information Security Board Meeting Date
Sattrix Information Security Ltd scheduled a board meeting for 04 November 2026 to consider H1 FY27 financial results. Trading window remains closed until 48 hours post-results.
Premco Global Board Meeting Date
Premco Global scheduled its board meeting for November 6, 2026, to consider Q1/H1 results. Dividend declaration is also on the proposed agenda.
Page Industries Board Meeting Date
Page Industries has intimated a board meeting on 12 Nov 2026 to consider Q2 FY27 unaudited results and 2nd interim dividend. Record date for the proposed dividend is 18 Nov 2026.